335 related articles for article (PubMed ID: 21949677)
1. Degradation of HIF-1alpha under hypoxia combined with induction of Hsp90 polyubiquitination in cancer cells by hypericin: a unique cancer therapy.
Barliya T; Mandel M; Livnat T; Weinberger D; Lavie G
PLoS One; 2011; 6(9):e22849. PubMed ID: 21949677
[TBL] [Abstract][Full Text] [Related]
2. Hypoxia-inducible factor 1alpha and antiangiogenic activity of farnesyltransferase inhibitor SCH66336 in human aerodigestive tract cancer.
Han JY; Oh SH; Morgillo F; Myers JN; Kim E; Hong WK; Lee HY
J Natl Cancer Inst; 2005 Sep; 97(17):1272-86. PubMed ID: 16145048
[TBL] [Abstract][Full Text] [Related]
3. PI3K/Akt is required for heat shock proteins to protect hypoxia-inducible factor 1alpha from pVHL-independent degradation.
Zhou J; Schmid T; Frank R; Brüne B
J Biol Chem; 2004 Apr; 279(14):13506-13. PubMed ID: 14726529
[TBL] [Abstract][Full Text] [Related]
4. Ηypoxia-inducible factor-1α, von Hippel-Lindau protein, and heat shock protein expression in ophthalmic pterygium and normal conjunctiva.
Pagoulatos D; Pharmakakis N; Lakoumentas J; Assimakopoulou M
Mol Vis; 2014; 20():441-57. PubMed ID: 24715760
[TBL] [Abstract][Full Text] [Related]
5. C-Terminal HSP90 Inhibitors Block the HIF-1 Hypoxic Response by Degrading HIF-1α through the Oxygen-Dependent Degradation Pathway.
Kataria N; Martinez CA; Kerr B; Zaiter SS; Morgan M; McAlpine SR; Cook KM
Cell Physiol Biochem; 2019; 53(3):480-495. PubMed ID: 31486323
[TBL] [Abstract][Full Text] [Related]
6. Immunoexpression patterns for Hypoxia-inducible Factor-1α and von Hippel-Lindau protein, in relation to Hsp90, of human brain tumors.
Assimakopoulou M; Androutsopoulou C; Zolota V; Matsoukas J
Histol Histopathol; 2016 May; 31(5):535-46. PubMed ID: 26592496
[TBL] [Abstract][Full Text] [Related]
7. COMMD1 Promotes pVHL and O2-Independent Proteolysis of HIF-1alpha via HSP90/70.
van de Sluis B; Groot AJ; Vermeulen J; van der Wall E; van Diest PJ; Wijmenga C; Klomp LW; Vooijs M
PLoS One; 2009 Oct; 4(10):e7332. PubMed ID: 19802386
[TBL] [Abstract][Full Text] [Related]
8. JNK1 mediates degradation HIF-1alpha by a VHL-independent mechanism that involves the chaperones Hsp90/Hsp70.
Zhang D; Li J; Costa M; Gao J; Huang C
Cancer Res; 2010 Jan; 70(2):813-23. PubMed ID: 20068160
[TBL] [Abstract][Full Text] [Related]
9. Bcl-2 regulates HIF-1alpha protein stabilization in hypoxic melanoma cells via the molecular chaperone HSP90.
Trisciuoglio D; Gabellini C; Desideri M; Ziparo E; Zupi G; Del Bufalo D
PLoS One; 2010 Jul; 5(7):e11772. PubMed ID: 20668552
[TBL] [Abstract][Full Text] [Related]
10. Hypoxia-inducible factor 1α mediates the down-regulation of superoxide dismutase 2 in von Hippel-Lindau deficient renal clear cell carcinoma.
Gao YH; Li CX; Shen SM; Li H; Chen GQ; Wei Q; Wang LS
Biochem Biophys Res Commun; 2013 May; 435(1):46-51. PubMed ID: 23611775
[TBL] [Abstract][Full Text] [Related]
11. Wogonin inhibits tumor angiogenesis via degradation of HIF-1α protein.
Song X; Yao J; Wang F; Zhou M; Zhou Y; Wang H; Wei L; Zhao L; Li Z; Lu N; Guo Q
Toxicol Appl Pharmacol; 2013 Sep; 271(2):144-55. PubMed ID: 23707765
[TBL] [Abstract][Full Text] [Related]
12. Hsp90 regulates a von Hippel Lindau-independent hypoxia-inducible factor-1 alpha-degradative pathway.
Isaacs JS; Jung YJ; Mimnaugh EG; Martinez A; Cuttitta F; Neckers LM
J Biol Chem; 2002 Aug; 277(33):29936-44. PubMed ID: 12052835
[TBL] [Abstract][Full Text] [Related]
13. Estrogen receptor α is a novel target of the Von Hippel-Lindau protein and is responsible for the proliferation of VHL-deficient cells under hypoxic conditions.
Jung YS; Lee SJ; Yoon MH; Ha NC; Park BJ
Cell Cycle; 2012 Dec; 11(23):4462-73. PubMed ID: 23159849
[TBL] [Abstract][Full Text] [Related]
14. Hypoxia-inducible factor-1 (HIF-1) promotes its degradation by induction of HIF-alpha-prolyl-4-hydroxylases.
Marxsen JH; Stengel P; Doege K; Heikkinen P; Jokilehto T; Wagner T; Jelkmann W; Jaakkola P; Metzen E
Biochem J; 2004 Aug; 381(Pt 3):761-7. PubMed ID: 15104534
[TBL] [Abstract][Full Text] [Related]
15. Spermidine/spermine N(1)-acetyltransferase-1 binds to hypoxia-inducible factor-1alpha (HIF-1alpha) and RACK1 and promotes ubiquitination and degradation of HIF-1alpha.
Baek JH; Liu YV; McDonald KR; Wesley JB; Zhang H; Semenza GL
J Biol Chem; 2007 Nov; 282(46):33358-33366. PubMed ID: 17875644
[TBL] [Abstract][Full Text] [Related]
16. Hemin, an iron-binding porphyrin, inhibits HIF-1α induction through its binding with heat shock protein 90.
Lee JM; Lee WH; Kay HY; Kim ES; Moon A; Kim SG
Int J Cancer; 2012 Feb; 130(3):716-27. PubMed ID: 21413014
[TBL] [Abstract][Full Text] [Related]
17. AT-533, a novel Hsp90 inhibitor, inhibits breast cancer growth and HIF-1α/VEGF/VEGFR-2-mediated angiogenesis in vitro and in vivo.
Zhang PC; Liu X; Li MM; Ma YY; Sun HT; Tian XY; Wang Y; Liu M; Fu LS; Wang YF; Chen HY; Liu Z
Biochem Pharmacol; 2020 Feb; 172():113771. PubMed ID: 31863779
[TBL] [Abstract][Full Text] [Related]
18. Kruppel-like factor 2 inhibits hypoxia-inducible factor 1alpha expression and function in the endothelium.
Kawanami D; Mahabeleshwar GH; Lin Z; Atkins GB; Hamik A; Haldar SM; Maemura K; Lamanna JC; Jain MK
J Biol Chem; 2009 Jul; 284(31):20522-30. PubMed ID: 19491109
[TBL] [Abstract][Full Text] [Related]
19. Interaction of the PAS B domain with HSP90 accelerates hypoxia-inducible factor-1alpha stabilization.
Katschinski DM; Le L; Schindler SG; Thomas T; Voss AK; Wenger RH
Cell Physiol Biochem; 2004; 14(4-6):351-60. PubMed ID: 15319539
[TBL] [Abstract][Full Text] [Related]
20. HIF-1α/GPER signaling mediates the expression of VEGF induced by hypoxia in breast cancer associated fibroblasts (CAFs).
De Francesco EM; Lappano R; Santolla MF; Marsico S; Caruso A; Maggiolini M
Breast Cancer Res; 2013; 15(4):R64. PubMed ID: 23947803
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
